论文部分内容阅读
Objective:Nebivolol, a third-generation β-adrenergic receptor (β-AR) blocker, has potential cardiac protective effects in obese individuals; however, the underlying mechanism remains unclear.In this study, we investigate the cardiac effects of nebivolol in a juvenile-adolescent animal model of diet-induced obesity.